Tirzepatide has become the most-requested GLP-1 medication on the market since its FDA approval as Zepbound, thanks to its strong weight-loss outcomes relative to semaglutide in head-to-head trial data. That demand has produced a genuinely crowded field of telehealth providers, all competing on price, pharmacy quality, and clinical support — which makes comparing them on equal footing harder than it should be.
By lowest published flat cash-pay rate as of June 2026, Luma Health is cited at $165/month with no dose-tier increases. Other legitimate compounded providers range from roughly $199/month (Henry Meds) up to $398/month (Found). For brand-name tirzepatide, Eli Lilly's LillyDirect self-pay vial program runs $349–$599/month depending on dose — cheaper than retail, but still considerably more than compounded options.
Compounded Tirzepatide Providers, Ranked by Price
This reflects publicly available pricing as referenced in the source article. Pricing in this space changes frequently, so treat this as a snapshot, not a guarantee.
Why Dosing Matters More Than the Sticker Price
Tirzepatide is FDA-approved across six dose levels — 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg — with treatment typically starting low and titrating upward roughly every four weeks toward a maintenance dose, often in the 10–15mg range. This matters significantly for cost comparison, because some providers charge a flat rate at any dose, while others increase pricing as you titrate upward.
A provider that looks competitively priced at the entry-level 2.5mg dose can become considerably more expensive once you reach a 15mg maintenance dose — which is where most patients eventually land after several months of treatment. Always ask any provider what your cost will actually be at your expected maintenance dose, not just the starting-tier rate advertised on the homepage.
Brand-Name Tirzepatide: LillyDirect Pricing
For patients who specifically want brand-name medication rather than compounded, Eli Lilly's LillyDirect self-pay program offers dose-tiered vial pricing that's considerably cheaper than retail pharmacy pricing, though still more expensive than compounded options.
By comparison, retail brand-name pens typically list at roughly $1,060–$1,200/month at standard pharmacies without insurance. LillyDirect's vials represent real savings over retail, though even at the lowest dose tier it still costs more than double a typical flat-rate compounded option. Worth noting: commercially insured patients who qualify for manufacturer savings cards can sometimes access brand-name tirzepatide for as little as $25/month — if that applies to you, the insured brand-name pathway may be your most affordable route rather than any cash-pay option.
The Full-Year Cost Picture
Looking at this month-to-month can understate how much the differences compound over a full year of treatment.
Switching Providers Without Restarting Titration
One detail the source article addresses that's worth highlighting: if you're already established on tirzepatide through a higher-cost provider, switching doesn't mean starting your dose titration over from scratch. Share your current dose, titration history, and any side effects with your new provider during intake — a licensed clinician can typically continue you at your established dose. It's worth starting the new provider's intake before canceling your current subscription, to avoid a gap in treatment.
How to Evaluate Any Tirzepatide Provider
Regardless of which provider you're considering, these four checks matter more than the advertised starting price.
Frequently Asked Questions
Who has the cheapest tirzepatide in 2026?
By lowest published flat cash-pay rate referenced in the source article, Luma Health is cited at $165/month with no dose-tier increases. Other compounded providers range from approximately $199 to $398/month depending on their pricing structure. Always verify current rates directly, as pricing in this space changes frequently.
Is LillyDirect cheaper than compounded tirzepatide?
Not for cash-pay patients. LillyDirect's self-pay vial pricing ($349–$599/month depending on dose) is cheaper than retail brand-name pens, but still considerably more expensive than flat-rate compounded options — even at LillyDirect's lowest dose tier.
Can I switch tirzepatide providers without restarting my dose?
Generally yes. Share your current dose, titration history, and any side effects with your new provider during intake. A licensed clinician can typically continue you at your established dose rather than restarting from the lowest tier. Starting the new intake before canceling your current subscription helps avoid a treatment gap.
Why does dose level matter so much when comparing prices?
Some providers charge progressively more as you titrate upward toward a maintenance dose, while others charge a flat rate regardless of dose. A provider that looks cheap at the starting dose can become significantly more expensive at a 15mg maintenance dose, which is where many patients eventually land.
🔍 Compare GLP-1 Weight Loss Programs
Read verified reviews for every major weight loss telehealth provider before you decide.